EUCTR2011-004748-23-DK进行中（未招募）1 期
Risk of apoplexia cerebri in clopidogrel non-responders. - Risk of apoplexia cerebri in clopidogrel non-responders.
eurologisk Afdeling0 个研究点开始时间: 2011年10月28日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •patientens with first-time ischemic apoplexia cerebri who recieves clopidogrel
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 150
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 150
排除标准
- •haemorrhagic stroke
- •Known cancer
- •other antiplatelet therapy treatment
研究者
相似试验
终止
不适用
RIsk of Apoplexia Cerebri in CLOpidogrel Non-respondersStrokeNCT02093299Zealand University Hospital165
已完成
不适用
Effect of clopidogrel in chronic brain ischemic patientsbrain ischemiaJPRN-UMIN000007915Kyoto university40
进行中（未招募）
1 期
Is cessation of clopidogrel therapy associated with rebound of platelet activity in stable vascular disease patients? - CLASP/platelet rebound after clopidogrelMedDRA version: 9.1 Level: HLT Classification code 10035523 Term: Platelet analysesMedDRA version: 9.1 Level: LLT Classification code 10007648 Term: Cardiovascular disease, unspecifiedCardiovascular diseaseEUCTR2007-007638-21-GBniversity of Aberdeen172
已完成
不适用
Is cessation of clopidogrel therapy associated with rebound of platelet activity in stable vascular disease patients?Cardiovascular and peripheral vascular diseaseCirculatory SystemAtherosclerosisISRCTN77887299Grampian Health Board and University of Aberdeen (UK)156
进行中（未招募）
1 期
Is intensive blood thinning with three antiplatelet drugs better than the current guideline treatment in reducing recurrence after acute stroke?EUCTR2007-006749-42-DKniversity of Nottingham4,100